Davita Inc. Stock
Davita Inc. Stock
Davita Inc. shows a slight decrease today, losing -€1.450 (-0.980%) compared to yesterday.
Our community is currently high on Davita Inc. with 5 Buy predictions and 1 Sell predictions.
With a current price of 145.2 € Davita Inc. is right around the predicted target price of 146 €.
Our community identified positive and negative aspects for Davita Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Davita Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Davita Inc. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Davita Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Davita Inc. | -0.980% | -0.650% | 4.686% | 56.028% | 53.781% | 40.561% | 183.041% |
Amn Healthcare Svs | 3.330% | -9.709% | -20.851% | -51.688% | -44.478% | -61.451% | -26.132% |
Ensign Group Inc. | -1.470% | -3.650% | 0.000% | 50.000% | 28.155% | - | - |
Chemed Corp. | 0.940% | 2.885% | 4.902% | - | - | - | - |
Comments
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at UBS Group AG from $169.00 to $175.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Bank of America Co. from $139.00 to $145.00. They now have an "underperform" rating on the stock.
Show more
Ratings data for DVA provided by MarketBeat
DaVita Inc. (NYSE: DVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for DVA provided by MarketBeat